This led the FDA to remove approval in June 2023. Supplemental warnings contain the hazards linked to cholestatic hepatitis, hypercalcemia in patients with breast most cancers, and greater chance for the event of prostatic hypertrophy and prostatic carcinoma in older sufferers.[10]As generally, you'll want to Stick to the guidelines supplied to ens